Naive embryonic stem cells hold great promise for research and therapeutics as they have broad and robust developmental potential. While such cells are readily derived from mouse blastocysts it has not been possible to isolate human equivalents easily 1, 2 , although human naivelike cells have been artificially generated (rather than extracted) by coercion of human primed embryonic stem cells by modifying culture conditions [2] [3] [4] or through transgenic modification 5 .
Here we show that a sub-population within cultures of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) manifests key properties of naive state cells. These naive-like cells can be genetically tagged, and are associated with elevated transcription of HERVH, a primate-specific endogenous retrovirus. HERVH elements provide functional binding sites for a combination of naive pluripotency transcription factors, including LBP9, recently recognized as relevant to naivety in mice 6 . LBP9-HERVH drives hESC-specific alternative and chimaeric transcripts, including pluripotency-modulating long noncoding RNAs. Disruption of LBP9, HERVH and HERVH-derived transcripts compromises self-renewal. These observations define HERVH expression as a hallmark of naive-like hESCs, and establish novel primate-specific transcriptional circuitry regulating pluripotency.
Although many genes are involved in pluripotency, transposable element transcription, particularly involving endogenous retroviruses (ERVs), has wired different genes into the pluripotency network in humans and mice 7 . Given a role for endogenous retroviruses in pluripotency [8] [9] [10] , we surveyed RNA-seq data of human pluripotent stem cells (hPSCs), notably hESCs and hiPSCs, finding that several transposable elements are expressed at higher levels in hPSCs compared with embryoid bodies (EBs) and human fibroblasts-ERV1 type of long terminal repeat (LTR) retroelements being foremost, of which HERVH was the most highly expressed 8, 11 ( Table 7 ). Higher transcription levels were associated with elements containing consensus LTR7 rather than diverged variants (LTR7B/C/Y; Supplementary Table 7) . Lower expression of other endogenous retroviruses (Fig. 1b) was confirmed via quantitative polymerase chain reaction with reverse transcription (qRT-PCR) (Fig. 1c) . We focused on HERVH as this was the only one detected by qRT-PCR in all hiPSC lines analysed (Fig. 1c) . Results are robust to use of reads that map to more than one location (Supplementary Table 16 ).
To address how specific HERVH transcription is to hPSCs we compared RNA-seq data sets of hPSCs and multiple differentiated cells and tissues (Extended Data Fig. 1c and Supplementary Tables 4, 5 and 7). In agreement with our hiPSC data, HERVH transcription was highest in hPSC lines. Most of the transcribed loci were identical between hiPSCs and hESCs (Extended Data Fig. 1c, d ). HERVH transcription levels were much lower in both differentiated cells and cancer cell lines (Extended Data Fig. 1c) .
HERVH transcription levels were higher in hiPSCs at early passages after reprogramming (Fig. 1d) , indicating that the reprogramming process itself might induce HERVH expression. At later passages the transcription of HERVH in hiPSCs approached hESC levels.
Consistent with HERVH transcription in hPSCs, ChIP-seq data show that, in contrast to HERVK and inactive HERVHs, active HERVHs are marked with transcriptionally active histone marks 11, 12 (H3K4me1/2/3, H3K9ac, H3K36me3 and H3K79me2), while the repressive marks (H3K9me3 and H3K27me3) are rare, indicating a function as active promoter/enhancers ( Table 15 ). HERVH activation is also inversely correlated with the DNA methylation status of the 59 LTR of HERVH, as shown by hypomethylation in active LTR7 regions in hPSCs 15 (Extended Data Fig. 2f ). To determine whether HERVH is a direct target of core pluripotencyassociated transcription factors, we interrogated HERVH in hESC_H1 ChIP-seq data 3 . This identified NANOG and OCT4 (also called POU5F1) Relative (Extended Data Fig. 3a) . A candidate KLF4 binding site was also identified within the LTR of HERVH (Fig. 2b) . We additionally asked which transcription factor motifs are significantly enriched across four in silico tests (Extended Data Fig. 3b ). Only one-LTR-binding protein 9 (LBP9) (also called murine Tfcp2l1)-was significant across all analyses (Extended Data Fig. 3b ). Tfcp2l1 is within the Oct4 interactome 16 and binds regulatory regions of Oct4 and Nanog 17 in mouse embryonic stem cells (mESCs). LBP9's direct binding to LTR7 is confirmed by ChIP-qPCR and electrophoretic mobility shift assay (EMSA) (Fig. 2c and Extended Data Fig. 3c ). EMSA further demonstrates LBP9 and NANOG cooperation in binding LTR7 (Extended Data Fig. 3c ), consistent with synergy after simultaneous overexpression (Extended Data Fig. 7c ). LBP9-specific binding was also detected in the 59 region of NANOG (Fig. 2c) .
In vitro differentiation assays showed that HERVH transcription levels declined over time in parallel with declines in OCT4, NANOG and LBP9 (Extended Data Fig. 3d ), suggesting a role in HERVH expression. As expected, ectopic expression of LBP9, OCT4, NANOG and KLF4 activated the pT2-LTR7-GFP#2 reporter and enhanced endogenous HERVH transcription levels in human primary fibroblast (HFF-1), whereas overexpression of MYC or SOX2 had no effect ( Fig. 2d and Extended Data Fig. 7c ). Conversely, a complementary 'loss of function' RNA interference (RNAi) assay in hESC_H9 revealed that HERVH transcription levels were reduced after knockdown of OCT4, NANOG and LBP9, but not SOX2 (Fig. 2e, f) .
We confirmed that LBP9 directly stimulates HERVH-driven expression, by comparing signals of a wild-type pT2-LTR7-GFP#1 reporter construct and a mutant lacking the LBP9 motif (DLBP9) in hiPSCs (Extended Data Fig. 7d ). When wild-type and mutant constructs were transfected into hiPSCs, the GFP signal was clearly detected from the wild-type reporter, but it was decreased by twofold in DLBP9 (Extended Data Fig. 7d) .
Embryonic stem-cell-specific transcription factors OCT4, NANOG, KLF4 and LBP9 thus drive HERVH transcription in hPSCs. In contrast to mice in which LBP9 binding sites are genomically distinct from those of other pluripotency transcription factors 6 , the key pluripotent transcription factors cluster within the primate-specific HERVH (Fig. 2b) .
To test the functional importance of HERVH, we analysed RNA-seq data to investigate the influence of HERVH on the expression of neighbouring regions. We find that LTR7 of HERVH initiates chimaeric transcripts, functions as an alternative promoter or modulates RNA processing from a distance (Fig. 3a, Extended Data Fig. 4b and Supplementary Tables 8  and 9 ). A total of 128 and 145 chimaeric transcripts were identified in hiPSCs and hESCs, respectively (Extended Data Fig. 4a and Supplementary Tables 8 and 9 ). One gene can contribute to multiple chimaeric transcripts. The chimaeric transcripts between HERVH and a downstream gene generally lack the 59 exon(s) of the canonical version (for example, SCGB3A2) while part of HERVH is exonized (for example, RPL39L) (Fig. 3a) . A significant fraction of HERVH sequence can be incorporated into novel, lineage-specific genes (for example, ESRG; Fig. 3a ) or long non-coding RNAs (lncRNAs) (for example, RP11-69I8.2; Extended Data Fig. 4d and Supplementary Table 10 ). We confirmed several hPSCspecific chimaeric transcripts by RT-PCR (Fig. 3a) . Transcriptional start signals commonly map to 59 LTR-HERVH boundary regions (Extended Data Fig. 4c ). Unlike the chimaeric transcripts, the canonical genes are commonly not expressed in pluripotent cells.
Nearly 10% of the transcripts driven by HERVH are annotated as lncRNA 12 (see Supplementary Table 11 for coding potential). Fifty-four transcripts were identified that are commonly detected in hPSCs, while the rest showed sporadic detection (Extended Data Fig. 4d ). The former set includes linc-ROR and linc00458, known to modulate pluripotency 18, 19 . Alignment of the 22 most highly expressed transcripts reveals an LTR-HERVH -derived conserved core domain (CD) (Extended Data Fig. 4f ). The domain is predicted to bind RNA-binding proteins, including pluripotency factors (for example, NANOG) and pluripotency-associated histone modifiers (for example, SET1A and SETDB1) (Extended Data Fig. 4g ). In agreement with a role in pluripotency, linc00458 physically interacts with SOX2 (ref. 19) .
To explore the effect of either LBP9 or specific HERVH-derived transcripts on the reprogramming process, we investigated whether forced expression of LBP9, ESRG or the conserved domain of lncRNAs (LTR7-CD) modulates the fibroblast-hiPSC transition. While the overexpressed gene products affect neither pluripotency nor self-renewal (Extended Data  Fig. 5a, b) , all facilitate reprogramming by accelerating the mesenchymalepithelium transition or hiPSC maturation ( Fig. 3b and Extended Data Fig. 5c ).
While LBP9 is key to the murine naive state 6, 20 , HERVH is primatespecific. To determine whether HERVH-LBP9 delineates a primatespecific pluripotency circuitry, we performed 'loss of function' experiments using small hairpin RNAs (shRNAs) against LBP9 or HERVH (Fig. 3c-f and Extended Data Fig. 5d-g ). Pluripotency-associated transcription factors and markers are downregulated whereas multi-lineage differentiation markers are upregulated upon knockdown of either LBP9 or HERVH, but not in shRNA controls (shGFP) (Fig. 3c, d and Extended Data Fig. 5f, g ). Depletion of LBP9 or HERVH in hESCs thus results in loss of self-renewal. Knockout of LBP9 similarly abolishes hESC selfrenewal (Extended Data Fig. 5h-j) . In contrast to hPSCs, the Tfcp2l1 (LBP9) knockdown in mESCs does not reduce levels of Oct4, Sox2 and Nanog in serum-based conditions (Extended Data Fig. 5k ) 21 , but only 
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in 2i (inhibition of ERK1 and GSK3b signalling with small molecules) 6 . In fact, Tfcp2l1 does not affect self-renewal, but rather differentiation potential (Extended Data Fig. 5k ).
Genome-wide gene expression patterns are highly similar between LBP9 and HERVH knockdowns (Fig. 3e) , consistent with LBP9 regulating HERVH-driven expression. A total of 1,094 of the 2,627 genes are similarly regulated in LBP9 and HERVH knockdowns ( Fig. 3f and Supplementary Table 12 ). While some HERVH-derived chimaeric transcripts are potentially directly affected by depletion of HERVH (Supplementary Tables 13, 14) , qRT-PCR identified 19 HERVH-derived lncRNAs downregulated in response to both HERVH and LBP9 knockdowns (Extended Data Fig. 4e ).
While several of the differentially expressed genes are associated with murine pluripotency, the LBP9-HERVH-driven list of transcripts defines a primate-specific pluripotency network. Our analyses defined two classes of genes. Class I genes contained those conserved between mouse and human that contribute to the pluripotency in both; class II contained a primate-specific group that includes (a) those with an orthologous partner, but are not involved in murine pluripotency, and (b) novel (not in mouse) transcripts (Extended Data Fig. 4b, d ). Several HERVH elements in class IIa affect gene expression in cis, and drive specific genic isoforms (for example, SCGB3A2). A subset of class IIb contains HERVH-derived novel sequences (for example, linc-ROR, linc000548, ESRG) (Extended Data Fig. 4d) .
We examined one class IIb transcript in detail. ESRG has a putative open reading frame (ORF) only in human (Extended Data Fig. 6a and Supplementary Data 1), and is uniquely expressed in human inner cell mass (ICM) and PSCs (Extended Data Fig. 6b ). Knockdown of ESRG compromised self-renewal of hESCs, as expression of many pluripotencyassociated genes was decreased, while SOX2 expression was slightly elevated (Extended Data Fig. 6c-e) . The ESRG knockdown colonies lost their hESC morphologies and committed to differentiation (Extended Data Fig. 6e, f) . Expression of ESRG along with OCT4, SOX2, KLF4 and MYC (OSKM) has a similar effect on the reprogramming process compared with LBP9 (Extended Data Fig. 5c ). ESRG is thus an HERVHassociated novel gene required for human-specific pluripotency, with a more specific phenotype than upstream regulators.
Given that the naive-associated transcription factors together cluster on HERVH and the HERVH-derived products are essential for primate pluripotency, we investigated whether HERVH-driven transcription marks the naive-like state in hPSC cultures. To explore this the reporter construct pT2-LTR7-GFP#2 was integrated into the genome of either mouse or human PSCs (Fig. 4a and Extended Data Figs 7a, b and 8i) by Sleeping Beauty gene transfer, providing stable transgene expression 22 . While all of the mESC colonies homogeneously express GFP (Extended Data Fig. 7a) , only ,4% of cells in each hESC colony show a strong GFP signal (GFP high ), indicating cellular heterogeneity (Extended Data  Fig. 7e, h-j) . The fraction either weakly or not expressing GFP we term GFP low and GFP
2
, respectively ( Fig. 4a and Extended Data Fig. 7b, e) . RNA-seq data of hESCs from single cells 23, 24 and hPSC lines confirm that pluripotent cultures exhibit variability in HERVH expression (Extended Data Fig. 1d ), indicating that the GFP high subpopulation may differ from the GFP low subpopulations. Consistent with a naive-like state, data mining of single-cell RNA-seq data sets 24 revealed that the expression level of HERVH in hESCs is correlated with several pluripotency-associated genes, including naive-associated transcription factors (Extended Data Fig. 1e ). Table 12 ).
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To collect uniform GFP high and GFP low hPSCs, we performed two rounds of fluorescence-activated cell sorting (FACS) (Fig. 4a) . We first sorted GFP 1 cells that were further divided into GFP high and GFP low categories. Notably, GFP high cells are capable of forming tight, uniformly expressing three-dimensional (3D) colonies characteristic of naive mESCs ( Fig. 4a and Supplementary Video 1) . In contrast, GFP low cells form flat colonies, resembling mouse epiblast stem cells (mEpiSCs) (Fig. 4a) . We also observed mosaic colonies. Immunostaining of 3D and chimaeric colonies revealed that the NANOG and GFP high signals co-present (Supplementary Videos 1 and 2). Thus, the GFP high subpopulation in human pluripotent stem cells is enriched for cells resembling the murine naive/ ground state.
To examine this possibility, we subjected GFP high and GFP low cells to expression analyses. qRT-PCR revealed significant upregulation of naive-associated transcription factors [4] [5] [6] and downregulation of lineagecommitment genes in GFP high versus GFP low cells (Fig. 4b) . As in naive mESCs 25 and human ICM 26 , X chromosomes are activated in GFP high hESC_H9, as evidenced by nearly complete loss of condensed H3K27me3 nuclear foci ( Fig. 4d ) and low levels of XIST expression (Fig. 4c) . However, nearly 60% of GFP low hESCs that transitioned from GFP high hESCs are marked with condensed H3K27me3 foci or higher density of H3K27me3 in the nucleus ( Fig. 4d and Extended Data Fig. 8g ). These data are consistent with a naive-like state for GFP high cells and a primed state for GFP low cells (one X chromosome inactivated or in the process of being inactivated).
GFP high cells can be maintained in the modified 2i/LIF medium for a long time, with higher single-cell clonality as well as full pluripotency (Extended Data Fig. 8a-d) . However, GFP high and GFP low cells have slightly different differentiation potential. When differentiation is triggered, certain naive-associated transcription factors are maintained at higher levels in GFP high naive-like cells compared with GFP low cells, and start their differentiation program with a delay (Extended Data Fig. 8e, f) . Early passage hPSC cultures behave similarly to GFP high cells (Extended Data Fig. 9a-c) .
Transcriptomes of GFP-sorted cell populations and previously characterized naive-like and primed hPSCs 4 . Approximately unbiased (au) probability, bootstrap probability (bp) values and edge numbers at P value less than 0.01 are shown. ICM clusters closest with GFP high -nodes 7, 9. f, Correlation matrix displaying the unbiased and pairwise comparison of mouse-human orthologous gene expression between GFPmarked hESC_H9 (this study, green) and mouse and human 4 naive as well as primed PSCs. Colour bar indicates Spearman correlation strength. g, Cluster analysis using the average distance method on the same data set as in f. GFP high , GFP 1 and GFP low cells in e-g were collected from hESC_H9 cells cultured in conventional human ESC medium by FACS sorting.
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the significance of HERVH-driven transcription defining a naive-like state.
To address how gene expression changes up to the ICM stage, we analysed 114 RNA-seq samples harvested in early developmental stages of embryogenesis 24 and 3 RNA-seq samples of naive-like hESCs (3iL_ hESC 3 ) . HERVH expression appears already in the zygote, but the pattern of activated loci changes during early development (Extended Data Fig. 9d, e) . Importantly, the pattern of active loci characteristic of ICM is the closest to naive-like hESCs, including GFP high cells (Extended Data Fig. 9d) . Notably, consistent with the active chromatin state, the number of activated HERVH loci in naive-like cells is particularly higher than in the primed hESCs (Extended Data Fig. 9d-f ), indicating that HERVH may have some involvement in the derivation and/or maintenance of naive-like hPSCs.
To address how HERVH-driven gene expression modulates pluripotency, we surveyed differentially regulated genes in GFP high versus GFP low cells, intersected by HERVH cis-regulation. The differentially regulated genes located in the neighbourhood (650 kb) of HERVH display a similar expression pattern to those differentially expressed in GFP high versus GFP low and in human naive-like versus primed stages, derived under specific culture conditions 4 (Extended Data Fig. 9h ). In contrast, a distinct pattern is observed when comparing mESCs versus mEpiSCs (Extended Data Fig. 9g ). Strikingly, there is an inverse pattern of expression between genes defining a naive-like stage (upregulated in GFP high versus GFP low ) and those that are downregulated in HERVH knockdowns (r 5 20.6, P = 0.0001; Extended Data Fig. 9i ), underlying the significance of HERVH in regulating the naive-like state in humans. Differentially expressed genes between GFP high versus GFP low populations were enriched for Gene Ontology (GO) terms of developmental processes, morphogenesis and organismal processes (Extended Data  Fig. 9j ). Transition of naive-like cells into a primed state after depletion of HERVH supports the above conclusion (Extended Data Fig. 9k ).
While GFP high cells have many properties resembling naive mESCs, they are better regarded as being naive-like, not least because it is unclear that human and naive mESCs need be identical. Indeed, while LBP9 is associated with pluripotency 6, 20 in mammals, HERVH was recruited to the pluripotency network exclusively in primates. How then to define naive human pluripotency if we do not necessarily expect cells in this state to be identical to those in mouse? We suggest that, rather than hardto-replicate inter-species chimaera experiments 27 , the optimal approach is to define cells by similarity of expression to the ICM (see Supplementary Discussion). In this regard, GFP high cells are one of the best current models of naive-like status.
That LBP9 forms heteromer complexes functioning either as a transcriptional activator or a repressor, depending on the partner 28 , is consistent with HERVH being recruited to the pluripotency network by serendipitous modification of a pluripotency factor detailed to defend the cell against it (Extended Data Fig. 10 ). Whatever the origin, LTR7 of HERVH is an efficient reporter for the naive-like state most probably because it acts as a platform for multiple key pluripotent transcription factors 29 . Similarly, the LTR7-GFP reporter should enable optimization of naive-like hPSC culture conditions.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Ethics approval. For work on human ES cells we obtained No. 6 allowance from the Robert Koch Institute, Germany (8 October 2004) . The human embryonic stem cell lines (H1, H9, BGN1 and BGN2) are permitted to be used in the study ''Mechanisms of single transduction in the maintenance of undifferentiated state in human embryonic stem cells''. Cell culture. Human foreskin fibroblasts (HFF-1) (ATCC, SCRC-1041) were cultured with the fibroblast medium (DMEM, 20% FBS, 1 mM L-glutamine, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol and primocin), and were passaged every 3-4 days. Human embryonic stem cells (hESCs) were cultured in matrigel/ feeder-coated plates in the conventional hESC medium (knockout DMEM, 20% knockout serum supplement, 1 mM L-glutamine, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol, 10 ng ml 21 bFGF (Pepro Tech, 100-18B) and primocin), or in naive hESC media NHSM 4 or 3iL 3 or in human 2i/LIF medium (this work). The human 2i/LIF medium is based on mouse 2i/LIF medium 6 (knockout DMEM, 20% knockout serum replacement, 1 mM L-glutamine, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol, 10 ng ml 21 LIF, 3 mM CHIR99021, 1 mM PD0325901 and primocin, but the CHIR99021 was changed from 3 to 1 mM, and the medium was supplemented with 10 ng ml 21 bFGF). The medium was changed daily. hESCs were treated with collagenase IV (1 mg ml 21 ) (Life Technologies, 17104-019) and then passaged onto new matrigel/feeder-coated plates every 4-5 days. The generation of hiPSC line hiPS-SB4 and hiPS-SB5 has been reported 30 . iPSC lines hCBiPS1 and hCBiPS2 and their culture conditions have been described previously 31 . They were derived from human cord-blood-derived endothelial cells (hCBEC) using a lentiviral vector expressing reprogramming factors OCT4, SOX2, NANOG and LIN28 (ref. 31) . Similarly, the line hFF-iPS4 (previously known as hiPS-SK4) was produced using HFF-1 cells and the same lentiviral overexpression construct. Successful reprogramming for the hFF-iPS4 cell line was verified by morphology, the expression of pluripotency markers, karyogram analysis and the ability to generate teratomas on immunocompromised mice (data not shown).
Mouse ESCs were cultured in gelatin/feeder-coated plates with the mESC medium (knockout DMEM, 15% fetal calf serum (FCS), 1 mM L-glutamine, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol, 10 ng ml 21 LIF (Millipore, LIF1010) and primocin) or mouse 2i/LIF medium 6 . To prepare feeders, mouse embryonic fibroblasts (passage 4) isolated from CF-1 mouse embryos were treated with mitomycin C (10 mg ml
21
) for 2-3 h. All above-mentioned cell cultures tested negative for mycoplasma infection. Karyotype of hESC_H9 was analysed using the G-banding method 32 indicating normal karyotype (Extended Data Fig. 8j ). Reprogramming assay. Reprogramming was performed as described previously 30, 33 . Briefly, 200,000 HFF-1 cells were transfected with pT2/RMCE-OSKM (2 mg) and pT2-CAG-amaxaGFP, or pT2-CAG-HA-LBP9, or pT2-CAG-ESRG, or pT2-LTR7-CD (1 mg per plasmid) using the Neon transfection system (Life technologies), and transposition was induced by SB100X 22 (1 mg). The transfected cells were plated onto matrigel-coated 6-well plates and cultured in the fibroblast medium (first 2 days), then medium was changed to the hESC medium (day 2 post-transfection). After 3 weeks, several hESC-like colonies were picked for expansion and characterization, while the rest of the colonies were fixed in 4% with paraformaldehyde and subjected to immunostaining. In vitro differentiation assay. To spontaneously differentiate hPSCs to embryoid bodies (EBs), hESCs/hiPSCs were cultured on geltrex-coated 6-well plates. Cells from one well were dissociated with collagenase IV (1 mg ml 21 ) for 5 min, and then split into small cell clumps. The small cell clumps were transferred into three 10-cm low-attachment dishes, and cultured in EB medium (knockout DMEM, 20% knockout serum replacement, 1 mM L-glutamine, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol and primocin). The medium was changed every 2 days. The embryoid bodies were cultured for 10 days followed by collection for RNA-seq or then replated in gelatin-coated 6-well plates for one week followed by immunostaining. Differentiation potential assay. GFP high and GFP low cells collected from the same FACS-sorted hESC clone were seeded on matrigel/feeder-coated plates, respectively. First, the GFP high and GFP low cells were cultured either in the human 2i/LIF medium or conventional hESC medium. Following 3 days culturing in the respective mediums, cells were exposed to EB medium. To improve single-cell-viability, the cells were treated with the ROCK inhibitor Y-27632 (Millipore, 10 mM) for 48 h before and after sorting. Immunostaining. hPSC colonies were cultured on matrigel/feeder-coated chamber slides (BD Biosciences). Following 3 days of culturing, cells were fixed for 30 min in 4% paraformaldehyde, permeabilized for 30 min in 1% Triton X-100, and blocked for 1 h in blocking solution (Applied StemCell, ASB0103). Fixed cells were incubated overnight at 4 uC with primary antibodies (OCT4, SOX2, NANOG, SSEA4, TRA-1-60, PAX6, TUBB3 (bIII-tubulin), SOX17, a-SMA and CDX2) (Supplementary Table 3 ). After washing in PBS, the cells were incubated with secondary antibodies (Life Technology) for 1 h at room temperature. DAPI (Sigma, D9564) was used for staining the nuclei. Immunostaining of reprogramming plates was performed as previously described 34 . Briefly, cells were fixed with 4% paraformaldehyde and stained with biotin-anti-TRA-1-60 (eBioscience, 13-8863-80) and streptavidin horseradish peroxidase (Biolegend, 405210), diluted in 1% Triton X-100 (containing 0.3% BSA). Staining was performed using the Vector labs DAB kit (SK-4100). Stained hiPSC colonies were counted with ImageJ software. Immunofluorescence microscopy to determine H3K27me3 in hESCs. GFP high cells were seeded on matrigel-coated coverslips in 12-well culture plates. Following 4 days of culturing, the cells were fixed with 4% paraformaldehyde (Sigma) supplemented with DAPI for 15 min, and permeabilized with 0.5% Triton X-100 for 5 min. Fixed cells were incubated with primary antibodies (NANOG or H3K27me3, Novus Biologicals and Millipore, respectively) overnight at 4 uC, then washed three times with PBS, and incubated with secondary antibodies (Alexa Fluor, Life Technologies) for 1 hour. After additional washing, the samples were mounted using ProLong Gold antifade reagent (Invitrogen) and images were taken using a Zeiss LSM710 pointscanning single-photon confocal microscope. 3D image movies were created by Imaris Imaging Software (Bitplane). To statistically compare X chromosome state in GFP high and GFP low cells which were transited from GFP high , images on GFP high and GFP low hESCs and female human fibroblast were analysed and quantified for the proportion of cells with condensed H3K27me3 foci which mark the inactive X chromosome. An average of 100-450 individual cells per samples from five images were counted. DNA constructs. The LBP9 ORF was amplified from human placenta cDNA by PCR with Pfu Ultra II Fusion HS (Agilent Technologies). A NotI restriction site was added to the 39 end of the fragment (for cloning purposes). A single, ,1,500-bp band was cloned into pJET1.2/blunt using the CloneJET PCR Cloning kit (Thermo Scientific). The LBP9 fragment was re-amplified from pJET1.2-LBP9 plasmid digested with NotI and was cloned into pHA5 expression vector. The HA-LBP9 fragment was cut from pHA-CAG-HA-LBP9 vector and cloned into the Sleeping Beauty transposon 35 , pT2-CAG-GFP vector. LPB9 expression from pHA-CAG-LBP9 or pT2-CAG-HA-LBP9 was confirmed by western blotting. The size of the observed band was in good agreement with the molecular mass of the full-length protein (54,627 Da). ESRG was PCR amplified from hESC cDNA (Pfu Ultra II Fusion HS). The MluI and BglII restriction sites were added to the 59 and 39 ends, respectively, for subsequent cloning. A single ,300-bp band was digested with MluI and BglII restriction enzymes, and then cloned into pT2-CAG-GFP vector. To clone pT2-LTR7-CD, 22 highly expressed, HERVH-derived lncRNAs were first aligned (Clustal Omega alignment tool), and the lncRNA core domain (CD) sequence (Supplementary Table 1) was synthetized. The synthetic LTR7-CD flanked by MluI/BglII restriction sites was cloned into the pT2-CAG-GFP vector by replacing GFP. Reporter assays. The individual HERVHs were compared with the HERVH consensus sequence from Repbase (http://www.girinst.org/repbase/). The ESRG locus of HERVH was selected to generate a reporter construct. Two different DNA fragments, #1 and #2, were amplified (for primers see Supplementary Table 1) . LTR7#1 (566 bp) contains the ESRG-LTR7 flanked by ,110 bp upstream genomic sequence, while ESRG-LTR7#2 (1,194 bp) contains the LTR7 plus sequence from the HERVHint. EcoRI and MluI restriction sites were added to the 59 and 39 ends of the fragments, respectively, for cloning purposes. The two DNA fragments were cloned into SB transposon-based pT2-CAG-GFP vector, digested with EcoRI and MluI (to remove CAG promoter) to generate pT2-LTR7-GFP#1 and pT2-LTR7-GFP#2. To clone an LBP9-motif deleted reporter construct, a 17-bp segment containing the LBP9 motif was removed from pT2-LTR7-GFP#1 by inverse PCR (Extended Data  Fig. 7d ). The PCR-amplified ,5,600-bp fragment was gel-isolated (Qiaprep, Qiagene), circularized and subsequently transformed into chemical competent DH5a cells. The deletion was confirmed by sequencing. The modified region was moved into the original vector by NcoI digestion. To generate multiple LTR7 reporter constructs (#3-#6), LTR7 was PCR-amplified from different genomic loci (Supplementary Table 1 ). The obtained fragments were gel isolated and cloned into pJet1.2 vector using the CloneJet PCR Cloning kit (Thermo Scientific) and confirmed by sequencing. In pT2-LTR7-GFP#3-#6, the LTR7 (flanked by StuI and Bsu36I) sequence of the pT2-LTR7-GFP#2 reporter was replaced by LTR7 (#3-6). Finally, these vectors were transfected into fibroblasts and hiPSCs for subsequent analyses. The transfected fibroblasts and hiPSCs were cultured in the conventional hESC medium. GFP 1 cells were quantified by FACS on day 6 post-transfection. Gain-of-function assays. Individual expression plasmid constructs containing OCT4, NANOG, SOX2, KLF4, MYC or LBP9 were transfected into 2 3 10 5 HFF-1s, respectively. The transfected cells were collected for total RNA extraction and qRT-PCR on day 4 post-transfection. Generating shRNA constructs. To generate shRNA against HERVH, we first aligned all active (based on RNA-seq data) full-length HERVHs and selected several conserved sequences. The selected conserved sequences were analysed by the Block-It RNAi Designer online program (https://rnaidesigner.invitrogen.com/rnaiexpress). The shRNA sequences of score .3.5 were further analysed for their specificity using
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BLAST against human genome. shESRG and shLBP9 targeting sequences were designed using the online siRNA design tool siDESIGN Center (http://dharmacon. gelifesciences.com/design-center/). 60-mer oligos were synthesized, and then cloned into the FP-H1 vector 36 . shRNA targeting GFP was used as a control. NANOG, OCT4 and SOX2 shRNAs were previously described 37 . Clones were verified by sequencing. For the list of shRNAs see Supplementary Table 2 . Generating stable shRNA knockdown hPSC lines. All of hESCs/hiPSCs were cultured under the same condition, including identical passage numbers. hESC/ hiPSC cultures containing spontaneously differentiated cells (.10%) were excluded from the knockdown experiments. shRNA plasmid (10 mg) for each gene was transfected into 1 3 10 6 hPSCs by the Neon transfection system followed by G418 (500 mg ml 21 ) selection on day 2 post-transfection until 7-10 days. Stable knockdown cell lines were harvested for FACS, immunostaining and RNA extraction. Transfection of hPSCs. Cells were treated with ROCK inhibitor Y-27632 (10 mM) (Millipore, 688000) overnight before transfection, and then trypsinized with Accutase (Life Technologies, A1110501) for 3 min at 37 uC to generate single-cell suspension. 5 3 10 5 hiPSCs or hESCs were transfected with certain plasmids using the Neon transfection system. The transfected hPSCs were immediately re-plated onto the matrigel/feeder-coated 6-well plates in hESC medium containing Y-27632 (10 mM). Four hours post-transfection, the medium was refreshed to remove the transfection buffers and dead cells. The hESC medium was changed daily. Note that the Neon transfection system was also used to transfect HFF-1, mouse embryonic fibroblasts, and mESCs (according to the manufacturer's protocol). Analysing hPSCs by FACS. Single-cell suspension was generated by treating hiPSCs/hESCs with Accutase for 3 min at 37 uC. 2 3 10 5 cells were incubated with anti-TRA-1-81-APC antibody (eBioscience, 17-8883-41) for 30 min at 4 uC in PBS. Cells were washed and suspended in ice-cold PBS before analysis on FACSCAlibur (BD Biosciences). 10,000 cells were typically analysed. Generating genetically LTR7-GFP marked hPSCs. Single-cell suspension of 5 3 10 5 hPSCs was transfected with 5 mg pT2-LTR7-GFP#2 and 500 ng SB100X using the Neon transfection system, and seeded onto matrigel/feeder-coated 6-well plates. One week post-transfection, hPSCs were treated with Y-27632 (10 mM) overnight, trypsinized into single cells, and purified with the feeder removal microbeads kit (Miltenyi Biotec, 130-095-531) before sorting by FACS. GFP 1 and GFP 2 were collected, respectively. The GFP 1 hPSCs were re-plated on matrigel/feeder-coated 6-well plates and cultured in hESC medium. One week later, the single GFP 1 colonies were picked up for expansion in hESC medium. The second round of sorting was performed on the expanded single clones to collect hPSCs expressing strong and low GFP signal (referred to as GFP high and GFP low ), respectively. The GFP high hPSCs were re-plated onto matrigel/feeder-coated 6-well plates and cultured in 2i/ LIF medium for further characterization. The pT2-LTR7-GFP#2-marked individual hESC-H9 clones, GFP high , GFP 1 and GFP low , were characterized in multiple assays. The integration site of the single copy pT2-LTR7-GFP#2 reporter in GFP high was determined (Extended Data Fig. 8i ). Single-cell cloning assay. 1,000 GFP high hESC_H9 collected from the second round of sorting were seeded onto one matrigel/feeder-coated well of the 6-well plate and cultured in 2i/LIF medium with or without Y-27632 (10 mM). 1,000 GFP low hESC_H9s were seeded onto one matrigel/feeder-coated well of the 6-well plate and cultured in hESC medium with or without Y-27632 (10 mM). One week after seeding the hESCs were fixed with 4% paraformaldehyde for 1 min, and then stained with alkaline phosphatase (Sigma, AB0300). Pictures of stained cells were analysed. Dark blue (undifferentiated), light blue (partially differentiated) and colourless (differentiated) colonies were counted, respectively. qRT-PCR. Total RNA was extracted from cells by using the Trizol kit (Invitrogen) following the manufacturer's instructions. 0.1 mg purified DNaseI-treated RNA, which was the mixture of biological triplicates, was used for reverse transcription (RT) (High Capacity RNA-to-cDNA kit, Applied Biosystems). Quantitative RT-PCR (qRT-PCR) was performed using the Power SYBR Green PCR Master Mix (Applied Biosystems) on the ABI7900HT sequence detector (Applied Biosystems). Data were normalized to GAPDH expression using the DDCt method. Error bars represent the standard deviation (s.d.) of samples carried out in triplicates. For the list of primers see Supplementary Table 1 . Electrophoretic mobility shift assay (EMSA). 2 3 10 6 hiPSCs were transfected with 20 mg plasmids encoding pT2-CAG-HA-LBP9. Two days post-transfection cells were collected and washed with PBS. Cells were lysed in 100 ml lysis buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 10 mM EDTA, 5% glycerine, 1% NP-40 and 13 protease inhibitor cocktail (Roche)) for 30 min at 4 uC. Following removal of the cell debris by centrifugation at 20,000g, binding reactions were performed in 25 ml volumes at room temperature for 30 min. DNA binding reactions contained FAM-labelled LTR7-specific, complementary dsDNA oligonucleotides (LTR7 oligo), HA-LBP9 containing cell extracts, 10 mM Tris-HCl pH 8.5, poly(dI-dC), 1 mM EDTA, 50 mM KCl, 10 mM 2-mercaptoethanol (see also Extended Data Fig. 3c ). Probe sequences are listed in Supplementary Table 1 . The gel buffer contained 50 mM Tris-borate pH 8.3, 1 mM EDTA. To super-shift specific complexes, cell extracts were incubated with antibodies (anti-LBP9 (Novus); anti-NANOG (Novus)) at 4 uC for 15 min before addition of the dsDNA oligonucleotides. Protein-DNA complexes were separated by electrophoresis in 6% non-denaturing polyacrylamide gels at 4 uC. Electrophoresis was performed at constant voltage of 200 V for 3, 4 or 6 h. The fluorescent signal was detected by using a FUJI FLA-3000 Imager. ChIP-qPCR. ChIP-qPCR was performed with the Transcription ChIP kit (Diagenode) according to the manufacturer's instructions with slight modifications. 1 3 10 7 hPSCs were fixed in 1% formalin/hESC medium (v/v) for 10 min with gentle agitation on a rotator at room temperature. Fixation was stopped by the addition of glycine (125 mM) and agitation for 5 min at room temperature. Fixed cells were washed twice in ice-cold PBS, re-suspended in 15 ml lysis buffer. Chromatin was sheared by sonication to about 100-500-bp fragments using a Bioruptor (Diagenode) and diluted into immunoprecipitation buffer. Anti-LBP9 (Novus) and anti-IgG (Abcam) antibodies were added to sonicated chromatin solution and incubated with preblocked protein A magnetic beads (Invitrogen) overnight at 4 uC with gentle agitation on a rotator. Immune chromatin-bead precipitates were collected by the magnetic device (Invitrogen) at 4 uC. Precipitates were washed sequentially with washing buffer (Diagenode). Immunoprecipitated DNA was eluted by incubating the beads with 150 ml elution buffer with gentle agitation for 25 min at room temperature. To reverse crosslinking, sodium chloride (final concentration of 0.2 M) was added to the eluates that were incubated overnight at 65 uC. DNA was purified according to the manufacturer's instructions. Purified DNA from input and immunoprecipitation was used as templates for Taqman qPCR to determine the occupancy of LBP9 on NANOG, LTR7, HERVH-int (gag and pol) and LTR5_Hs. Primer and probe sequences are listed in Supplementary Table 1 . Analysis of genomic integration sites of the reporter construct in hESCs. The reporter LTR7-GFP#2 was cloned into Sleeping Beauty-based cloning vector pT2. The reporter was integrated into hESCs_H9 by co-transfecting the SB100X transposase 22 . Using sorting and re-plating (Fig. 4a) , a single GFP 1 colony was picked and expanded for further characterization of naive and primed cells. Integration sites of the reporter in the GFP 1 colony was determined by splinkerette PCR as described previously 30 with slight modification. Genomic DNA (gDNA) was isolated from GFP 1 hESC_H9, and 1 mg gDNA was digested with DpnII and BfuI overnight, respectively. The digested gDNA was purified with the QIAquick PCR Purification kit (Qiagen), and then ligated to MboI splinkerette linkers overnight. Five microlitres of the ligation reaction product were used for the first round of PCRs with a cycle of 96 uC for 2 min, followed by 10 cycles of 92 uC for 40 s, 60 uC for 40 s and 72 uC for 2 min with a decrease of 1 uC per cycle; 10 cycles of 92 uC for 40 s, 63 uC for 40 s and 72 uC for 1 min with a decrease of 0.5 uC per cycle; 25 cycles of 92 uC for 40 s, 50 uC for 40 s and 72 uC for 1 min; The final elongation was performed for 10 min at 72 uC, and then cooling to 4 uC. The second round of PCR (nested PCR) was done with primers Nested and T-Bal with a cycle of 2 min at 96uC followed by 6 cycles of 92 uC for 40 s, 66 uC for 40 s and 72 uC for 1 min with a decrease of 1 uC per cycle and 14 cycles of 92 uC for 40 s, 59 uC for 40 s and 72 uC for 1 min. The final elongation was performed for 10 min at 72 uC. Finally, the purified PCR products from the nested PCR were sequenced, showing the same single PCR product under different enzyme digestion. The linkers and primers used in splinkerette PCR are showed in Supplementary Table 1 . Knockout of LBP9 in hESCs. The published CRISPR/Cas9 vector X330 38 was modified for the knockout (KO) of LBP9 in this study. Two guide-RNA (gRNA) sequences targeting the second exon of LBP9 were designed according to the guide RNA design tool (http://crispr.mit.edu/). gRNA sequences were then synthesized and ligated into the vector of X330 to generate two LBP9 knockout vectors, referred to as CRISPR/ Cas9-gRNA(LBP9)#1 and #2. A total of 2.5 3 10 5 hESC_H9 were transfected with 2.5 mg CRISPR/Cas9-gRNA and 1 mg pT2-GFP, and then seeded onto matrigel/feedercoated 6-well plates. The cells transfected with Cas9 and pT2-GFP were used as controls. The transfected hESCs were cultured in conventional hESC medium. To enrich for targeted events, GFP 1 cells were sorted by FACS and re-plated onto matrigel/feeder-coated 6-well plates on day 2 post-transfection. On day 6 posttransfection, single cell suspensions were immunostained with TRA-1-81, and sorted to collect GFP 1 /TRA-1-81 1 (undifferentiated) and GFP
1
/TRA-1-81 2 (differentiated) cells, respectively. Genomic PCR was performed on genomic DNA isolated from these undifferentiated and differentiated cells, respectively. PCR products were subjected to TA cloning and sequencing. The gRNA and primer sequences are in Supplementary Table 1 . Gene expression microarrays. Total RNA was isolated from hESCs using the RNeasy kit (Qiagen). The quality of total RNA was checked by gel analysis using the total RNA Nano chip assay on an Agilent 2100 Bioanalyzer (Agilent Technologies). Only samples with RNA index values greater than 8.5 were selected for expression profiling. 100 ng of total RNA was simultaneously processed from each sample. Biotin-labelled cRNA samples for hybridization on Illumina Human Sentrix-12 BeadChip arrays (Illumina, Inc.) were prepared according to Illumina's recommended sample labelling procedure. Data extraction was done for all beads individually, and LETTER RESEARCH outliers were removed when .2.5 MAD (median absolute deviation). All remaining data points were used for the calculation of the mean average signal for a given probe, and standard deviation for each probe was calculated. RNA-seq. Total RNA was extracted from three types of cells-hiPSCs, HFF-1, EBs differentiated from hiPSCs using Trizol (Invitrogen)-following the manufacturer's instructions. After extraction a DNase treatment was applied using TURBO DNAfree kit (Ambion) and a second RNA extraction with Trizol was performed, and further PolyA(1) RNA extraction and RNA-seq library construction followed Illumina TruSeq RNA Sample Preparation Kit protocol. Sequencing was performed on the Illumina HiSeq 2000 machine with single-end 101 cycles. Statistical analysis. All data were collected from at least two biological replicates and from at least two independent experiments. No statistical method was used to predetermine sample size. Sample sizes were based on previously published experiments which are similar to the present study. Experiments were not randomized. The investigators were not blinded to the group allocation during the experiments or outcome assessment. All data are shown as mean and standard deviation (s.d.) of multiple replicates/experiments (as indication in figure legends) . Analysis of all experimental data was done with GraphPad Prism 5 (San Diego, CA). P values were calculated with two-sided, unpaired t-test following the tests for differences in variances as specified in the figure legends. P values less than 0.05 were considered significant. Sequencing and mapping. In the pilot study, RNA-seq reads were first filtered by Illumina quality control and then mapped to the human genome (hg19: http:// genome.ucsc.edu/) by TopHat-1.3.0 39 (parameter settings: -solexa1.3-quals -g 100 -p 4-segment-mismatches 3 -segment-length 30). Only the aligned reads with unique location in the genome were used for further analysis. At the extended study, we collected 269 samples from 14 independent published studies for pluripotent stem cells (hiPSC and hESC), somatic tissues, cancer cell lines and cells from early embryos (Supplementary Tables 4 and 5 ). The RNA-seq reads from these published samples and our pilot study were mapped by STAR mapper 40 (parameter settings: -readFilesCommand zcat -runThreadN 10 -genomeLoad LoadAndRemove -outFilterMatchNminOverLread 0.66 -outFilterMismatchNoverLmax 0.05 -outFilterMultimapNmax 100). To control the quality of the data, we only chose the ones with more than half of the total reads being uniquely mapped and the number of uniquely mapped reads larger than 10 million. For mapping details see Supplementary Table 6 . For part of the ChIP-seq analysis, the raw sequencing reads were mapped by bowtie2 with default parameter settings 41 and MACS software 42 was further applied for the peak calling. Gene expression calculation. Gencode V14 human gene annotation was downloaded from GENCODE Project (http://www.gencodegenes.org/). The number of uniquely mapped reads was calculated on each annotated gene, and further normalized to reads per kilobases per million (RPKM) by total number of uniquely mapped reads. At the extended study, featureCounts 43 was used for counting the number of uniquely mapped reads at exonic regions of annotated genes. Expression calculation of repeated elements. The human RepeatMasker annotation file was downloaded from UCSC Tables (http://genome.ucsc.edu/cgi-bin/ hgTables?command5start), and used as repeat annotation standard in our analyses. The number of reads, uniquely mapped to repeated elements annotated by RepeatMasker, was calculated by featureCounts 43 , which was further RPKM normalized by total number of uniquely mapped reads. Using uniquely mapped reads, we first calculated the total number of the reads deriving from all repeated elements and each repeat family, respectively. Next we computed the relative abundance and enrichment level of each repeated family. Specifically, the relative abundance of repeated element family A is the percentage of reads allocated to family A, divided by total reads of repeated elements. The enrichment level was calculated using the formula (N i 3L)/(N3L i ), where N i is the number of reads allocated to a specific repeated family, N is the total number of reads allocated to all repeated elements, L i is the total length of the specific repeated family and L is the total length of all repeated elements. To determine the relative abundance and enrichment of LTR elements, we applied the above strategy, except reads of all LTR elements were used instead of all repeated elements. One-tail binomial test was applied as a statistical tool.
To determine the expression level of HERVH, full-length HERVH was defined as LTR7-HERVH-int-LTR7. First, RepeatMasker was used to annotate all repeated elements, and HERVH-int and LTR7 terminals were mapped to the whole human genome (hg19). Then, the distribution of the distances between HERVH-int and neighbour LTR terminal fragments was calculated, and the HERVH-int and LTR terminal elements within the 99% quantile of the distance distribution (2,655 bp) was further merged. The median size of the full-length HERVHs was found to be 5,750 bp. Using the above strategy, 1,225 full-length HERVHs were identified in total, including 1,057 elements with LTRs at both ends (DiLTR), 159 HERVHs with one terminal LTR (monoLTR) and 9 HERVHs with no recognizable LTR (NoLTR) (Supplementary Table 7 ). The expression and enrichment level of full-length HERVHs was calculated by the same procedure as above. To define the transcriptionally active and inactive loci of HERVHs in hPSC samples, we analysed 1,225 full-length HERVH elements by the hierarchical cluster analysis. The hierarchical distances among samples were based on Spearman's correlation coefficient. To minimize the total within-cluster variance the hierarchical distances among full-length HERVHs were calculated by the Euclidean distance with Ward's method. All calculation was based on raw normalized expression value (RPKM). To visualize the expressed HERVH elements, HERVHs with expression levels with or above 8 RPKM were capped to 8, while the ones equal to or below 0.125 were treated as 0.125. During logarithmic transformation process a small number (0.01 RPKM) was added to the expression level of all the genes or repeated elements to handle instances of zero expression. Identification and characterization of HERVH-derived chimaeric transcripts and HERVH neighbouring genes. The search for HERVH-derived chimaeric transcripts in hPSCs was done by looking for the junction reads that have one part mapped to the exon-free full-length HERVH region and another part mapped to the exonic region of annotated protein-coding genes. The expression level of chimaeric transcripts was quantified by counting the number of reads sharing the same chimaeric junction. Chimaeric transcripts supported by at least 10 junction reads were used for analysing samples from inter-cell-type comparison (Supplementary Tables 8 and 9 ). The neighbouring gene of HERVH is defined as the closest gene(s), while HERVH-derived genes are the ones whose exonic regions overlap with HERVH. To determine the transcription start site (TSS), we re-analysed the published hESC_H1 CAGE data from the ENCODE project. The relative location of TSSs on active HERVH elements was profiled. We calculated (1) the density distribution of CAGE fragments around HERVHs, and (2) their relative position in LTR7-HERVH-int-LTR7. The positive value of the peak indicates that TSS is mainly located at the HERVH-LTR boundary regions (Extended Data Fig. 4c ). ChIP-seq comparative analysis. Global hESC_H1 chromatin statuses based on HMM method was proposed by Ernst et al. 44 and was downloaded from ENCODE (https://genome.ucsc.edu/ENCODE/). Then, ChIP-seq peak files and bigWig files for H1 DNaseI hypersensitivity and histone modification information were also downloaded from the same source. Furthermore, bigWig files for H3K9me3, H3K27me3 and H3K4me3 in penis foreskin fibroblast primary cells, H1-hESC and hiPSCs were downloaded from Epigenome Atlas (http://www.genboree.org) for inter-cell type comparison. In the comparison of histone modification between naive-like stem cells and primary stem cells, the peak files provided by Gafni et al. 4 and the raw sequencing data provided by Chan et al. 3 were downloaded from the corresponding sources, and their processing is described in the sequencing and mapping sections. Bwtools (https://github.com/CRG-Barcelona/bwtool/wiki) 45 was applied for facilitating bigWig file processing, where aggregate function was used for the calculation of average ChIP-seq signal surrounding given regions and matrix function was used for ChIP-seq signal detection around each given region. In the comparative study of ChIP-seq peak enrichment analysis (Fig. 2a and Extended Data  Figs 2a and 9f) , the ChIP-seq peaks within 10 kb of HERVH centres were kept for the analysis, and the distances of these peaks to the closest HERVH boundaries were calculated, where the mean difference between the distances for active ones and inactive ones was compared by Student's t-test. At the same time, the number of active HERVHs or inactive ones containing ChIP-seq peaks within 10 kb of their centres was calculated, and two-sided binomial test was applied for the significance calculation of peak enrichment in active ones. In the comparative study of the difference of ChIP-seq coverage distributions between active HERVHs and inactive ones, the areas within 10 kb of HERVH boundary were considered, and the coverage levels for different loci within this region were calculated in continuous 10-kb windows. Transcription factor analysis. To identify candidate transcription factors binding HERVH we took in silico and data mining approaches. In silico: CLOVER 46 was used to compare active HERVHs against GC matched control using the JASPAR core vertebrate motifs (http://jaspar.genereg.net/cgi-bin/jaspar_db.pl?rm5browse &db5core&tax_group5vertebrates). GC matched controls were 20-kb sections of the human genome 59 of known genes and within 0.05% of the GC content of the focal sequences. Using ROVER 47 we determined motifs enriched in the more active HERVHs, those with LTR7, compared with those that are active but less so (those with LTR7C/Y). In addition we compared the standard version of LTR7 (seen in HERVH) against the less active HERVH sequences and compared the active HERVH sequences with HERVK active sequences (Extended Data Fig. 3b ). OCT4 and NANOG ChIP-seq data 3 in hESC_H1 were downloaded from ArrayExpress (E-MTAB-2044). The raw sequencing reads were mapped to human genome (hg19) by bowtie2 with default parameter settings 41 , and MACS software 42 was further applied for the peak calling. DHS analysis. ENCODE project 48 DHS files were downloaded in bed format. The 'closest' method in Bedtools 49 was used to find overlapping or the closest DHSs. To investigate the statistical significance of the number of sequences including one or more DHSs, we conducted a Monte Carlo simulation. According to the transcriptionally active HERVHs, we generated random sequences of the same length on the same chromosome and then counted the number of sequences including DHSs.
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We repeated this 10,000 times and counted how many of iterations included more or the same number of DHSs than observed in our active HERVH sequences (none). To enable accurate estimation of type I error rate, we define P 5 (n 1 1)/(m 1 1), where n is the number of observations as or more extreme than observed and m the number of trial runs. A vicinity of 1.5 kb on both sides of sequences was also searched for DHS. We used chi-square to compare observed number of inactive sequences overlapping one or more DHS with the number we would expect if there was no difference between the two. Analysis of chromatin marks and DNA methylation. The methylation profiles of H3K4me3 and H3K27me3 in hESC_H7 are available at the ENCODE portal. We focused on the data sets generated by standard protocols. We compared averages for histone marks H3K4me3 and H3K27me3 on active and inactive HERVHs and also LTR7. We counted the number of methylation sites reported for each group and kept the extension size 1.5 kb consistent with DNase analysis.
We also compared CHD1's binding sites in active and inactive extended HERVH. CHD1 binding sites in ESCs were downloaded from ENCODE (http://genome.ucsc. edu/cgi-bin/hgFileUi?db5hg19&g5wgEncodeSydhTfbs, accessed on 7 December 2012). HERVH sequences were extended 1,500 bp on both sides and the number of CHD1's binding sites overlapping the extended sequences determined. Chi-square test was employed to test for significance. A similar method as the one explained for histone methylation analysis was used to calculate the expected value. We also compared binding sites of MYC, MAX and CHD2 chromatin remodellers, available through the ENCODE portal (http://genome.ucsc.edu/cgi-bin/hgFileUi?db5 hg19&g5wgEncodeSydhTfbs, Release 3, accessed on 7 December 2012). Using the same approach as above we compared active and inactive extended HERVH, its LTR7 and also HERVK and its LTR5.
To study the global DNA methylation status of HERVHs in hPSCs, we downloaded the genome-wide bisulphite sequencing data in wig format from Epigenome Atlas (http://www.genboree.org/epigenomeatlas/index.rhtml) for hiPSCs, H1s and penis foreskin fibroblast primary cells (see Supplementary Table 4) . We used BEDtools 49 (https://code.google.com/p/bedtools/) to extract the methylation scores for detected CpGs in each HERVH-associated LTR7, and then calculated the average methylation level for each LTR7. To compare DNA methylation status differences of HERVH-associated LTR7s in hPSCs versus fibroblast cells, we applied one-sided Wilcoxon rank sum test. Estimating the coding potential of the HERVH-driven ncRNAs. We established a set of putative ncRNAs that appear to be HERVH associated. For each of these we queried LNCipdedia 50 (http://www.lncipedia.org/) via gene name, or if that failed, via transcript ID. If present this resource reports Coding Potential Calculator (CPC) scores 51 , possible Pfam motifs and presence in the PRIDE database (a database of mass spectrometry identified proteins including small peptides). As all of the sequences are PRIDE negative we don't report this. In the few instances where the transcript was unknown to LNCipedia we determined CPC and Pfam scores via the CPC website (http://cpc.cbi.pku.edu.cn/). CPC values under zero are considered evidence for non-coding potential. Scores between 0 and 1 are weak candidates for coding function. Scores over one are considered as stronger evidence for coding. Nine of the RNAs have negative CPC scores (meaning most likely to be ncRNA), 18 have scores between 0 and 1 (possibly with small fragment that might be protein coding) and 7 have scores over 1 (meaning that they are more likely to have coding potential) (Supplementary Table 11 ). HERVH-derived lncRNAs and shHERVH targeting prediction. We searched HERVH-derived lncRNAs by looking for the lncRNAs with exonic regions overlapping with hPSC-specific full-length HERVHs (Supplementary Table 10 ). The annotation of lncRNAs was downloaded from Gencode V14 (http://www.gencodegenes. org/). Using the sequences of the shHERVH constructs, used in the knockdown experiments (shHERVH#3, shHERVH#4 and shHERVH#12), we predicted their targets (21-bp perfect matching). Next, we identified genes that either form chimaeric transcripts with the targeted HERVHs or are derived from them. Using our global gene expression profiling data (Illumina), we also examined if any of these genes are significantly downregulated (one-sided Student's t-test, P values adjusted by Benjamini and Hochberg method). Global gene expression analysis. Expression data was processed from bead-level expression intensity values pre-processed from Illumina's software in the form of .txt or .bab files carrying 48,324 probe sets targeted by HumanHT-12 v4 Expression BeadChips. Green intensities were extracted after adjusting non-positive values by BeadArray's (http://bioconductor.org/biocLite.R) built in functions. Furthermore, to the BeadArray output data, we fetched significance level of normalized expression values corresponding to probe ID using the lumi (http://www.bioconductor.org) package. We exploited inbuilt functions of this package such as variance-stabilizing transformation (VST) to deal with sample replicates and robust spline normalization (RSN), for normalization, of which P value ,0.05 were further transformed onto log 2 scale. Probe IDs were annotated by using Bioconductor package (http:// www.bioconductor.org/packages/release/data/annotation/html/illuminaHumanv4. db.html). Expression values of multiple probes for one gene were assigned by their median, resulting in 20,394 unique genes for GFP-marked samples.
In this study, fold-change of differential expression between samples on log 2 scale was analysed using linear and Bayesian model algorithms from limma (http:// bioconductor.org/) and pairwise differential expression between samples from various data sets was performed by the correction of batch effect arising from two different platforms by normalizing (quantile) each data set to a sample of the same genotype and merging data sets for downstream analysis. Heat maps (Fig. 3e) shown for differential expression among LBP9 knockdown and HERVH knockdown (shLBP9 and shHERVH) and control (shGFP) samples were drawn for genes, showing significantly highest standard deviations, on their Z-score. The matrix was hierarchically clustered (Spearman correlation and distances between observations were calculated using euclidian distances and average linkage). We exploited the online tool GOrilla (http://cbl-gorilla.cs.technion.ac.il/) to check for biological processes functional enrichment (Extended Data Fig. 9j ) of differentially expressed genes where the entire gene list was used as background. A false-discovery-rate-corrected P-value threshold was set at 0.05.
Comparison of global expression profile of human ICM, hESC 52 (GSE29397) and GFP-marked samples (present study) represented gene-wise (19,103 genes possessing common probes between two platforms) were subjected to hierarchical clustering (Pearson correlation, centroid linkage, k 5 3), whereas samples were clustered using Spearman correlation, centroid linkage and height represent the units of euclidean distance. In Fig. 4e , g, units for height on y axis represent the distance (D), which is the value of criterion associated with method by which they are clustered (D 5 12C; C, correlation between spot clusters). Differentially expressed gene-list between GFP high and GFP low samples (FDR ,0.05) were intersected to cross-platform, pairwise comparison of rescaled expression values of genes assigned as their row-wise Z-score (expression value subtracted by mean of its row values and divided by its standard deviation). Neighbouring genes were fetched using bedtools falling in the window of 50 kb from HERVH genomic coordinates, fold changes between naive and primed were calculated independently, keeping thresholds for human and mouse samples in the same way as mentioned above, data sets were intersected by gene names, and heat maps were drawn on their calculated Z-scores.
Cross-species gene expression analysis (see ref.
4) was performed on human with Illumina HumanHT-12 v4 (expression beadchip containing 47,324 probes, present study) and Affymetrix HuGene 1.0 ST microarrays (containing 33,252 probes, GSE46872) and on mouse with Agilent 4x44K array platform (containing 45,018 probes, GSE15603) microarray expression sets. Human-mouse orthologous genes were downloaded with an online tool (biomart) from Ensemble (http:// www.ensembl.org/biomart/martview/) containing 18,657 pairs of orthologous genes; out of these a total of 9,583 genes were mapped by probes of both human and mouse array platforms and explored in the present study, which were implemented for further analysis. The expression value of each gene was determined by median of all probes targeting to it. As mentioned above, the batch effect was corrected; correction was confirmed by Principal Component Analysis (PCA). Next, these independent data sets were merged in one for further analysis. Each gene value was further assigned as their relative abundance value, which is the expression value of a gene in each sample divided by the mean of expression values of corresponding genes across the samples within the same species. The resulting expression matrix (Fig. 4f ) was subjected to hierarchical clustering (Spearman's correlation, average linkage); the P value threshold for the correlation test for the matrix was kept up to 0.01. Whereas outliers are not shown in the coloured matrix, the hierarchically clustered dendrogram displays all of the samples included in the analysis. were re-analysed along with previously described naive and primed samples 4, 53 . These data sets were generated on different platforms, so they were subjected to the same pre-processing. In brief, we fetched 19,102 common genes probed on all the platforms, with the value of individual gene denoting the mean of its expression value. The batch effect resulting from two different platforms was removed by quantile normalization of each data set to a sample of the same genotype which was then excluded from analysis. Additionally, batch effect arising from ICM data was corrected by quantile normalization to the mean values of its ESC samples, which enabled it to be consistent with the normalized data sets of GFP, naive and primed samples. The samples were hierarchically clustered using average linkage and Spearman correlation as a distance matrix via multi-scale bootstrap resampling, replicated 1,000 times. Moreover, P values were computed for each of the clusters by approximately unbiased and bootstrap probability, which enabled us to assess the uncertainty in hierarchical cluster analysis. Outlier samples (approximately unbiased and bootstrap probability ,50%) are not shown in the plot (Fig. 4e) but were included throughout statistical analysis. Graphics. Graphics (for bioinformatics analyses) were done in R (http://www. r-project.org/), and ggplot2 (http://ggplot2.org/) was used for part of the graph making. -dC) ). Complex 1 has lower stability (adding equal amount of competing oligonucleotide to the binding reaction doesn't destroy it, but 1003 excess does). Supershift is not detected with adding anti-LBP9 antibody, suggesting a lack of specificity, at least under our conditions. Complex 2 is resistant to being challenged with the competing oligonucleotide (100-fold excess), and supershifts with anti-LBP9 antibody, indicating specificity. From the low mobility we suspected that complex 2 is a large multimeric complex-this would also account for the modest but reproducible supershift. To explore the potentially multimeric nature of complex 2, we added anti-NANOG antibody. The supershift with anti-NANOG indicates that LBP9 binds LTR7 in a complex with NANOG. ESRG-oligonucleotide 50 nM (1); poly(dI-dC) 450 ng (1), 900 ng (11); anti-LBP9 5 mg (1), 10 mg (11); anti-NANOG 5 mg; competitor oligonucleotide 5 nM (1), 500 nM (11), 5,000 nM (111); mutant oligonucleotide 50 nM; LBP9 ,10 mg crude extract lysate in 20 ml total reaction volume. NS, nonspecific complex. For a list of oligonucleotide sequences, see Supplementary Table 1 a, HERVH affects the neighbouring gene expression and produces HERVHspecific 'chimaeric' transcripts (RNA-seq reads which span HERVH and coding exons of neighbouring genes). Venn diagram shows the overlap between affected genes (see also Supplementary Tables 8 and 9 ). Examples of genes from each category are shown in boxes. b, Genes associated with HERVH function in stem cells with previously described gene functions. c, TSS distribution around HERVHs and the relationship between TSS identification and gene activity. CAGE data (from ENCODE) were analysed to identify TSS enriched on 59 end active HERVHs. d, Expression heat map of 54 HERVHderived lncRNAs in hPSCs and differentiated cells. Analysis of RNA-seq data sets as in Extended Data Fig. 1c . Data are displayed as log 2 RPKM with high and low expression shown in red and blue, respectively. EB, embryoid body (data from this study). e, Knockdown effects of LBP9 and HERVH on the highest expressed lncRNAs in hPSCs (selected from the list presented in d). mRNA levels are normalized to GAPDH, and relative to shGFP expressing, undifferentiated hESC_H9. Fold-change values relative to shGFP knockdown are shown. Note that the knockdown effects of LBP9 and HERVH are highly similar. f, Alignment of top 22 hPSC-specific/HERVH-derived lncRNAs predict a conserved core domain (CD, referred as LTR7-CD). Certain CDs, embedded within lncRNAs, are annotated as exons and predicted to have limited coding potential (see also Supplementary Table 11) . g, Heat map of potential RNA-protein interactions (predicted by CatRAPID 54 ). lncRNAs were selected from Extended Data Fig. 4f if they were: (1) highly expressed in hESCs; (2) downregulated in HERVH knockdown; (3) enriched in nucleus. The Z-score describes the deviation of the studied RNA-protein interaction propensity from the ones based on randomized 100 RNAs against randomized 100 proteins (calculated by CatRAPID). The core domain of HERVH-derived lncRNAs is predicted to bind RNA-binding proteins, including pluripotency factors (for example, NANOG), and histone modifiers (for example, SET1A and SETDB1). High and low interaction potentials are shown in red and blue, respectively. Table 14 . e, Validation of the shHERVH constructs. Stable, G418-resistant hESC-derived colonies express various shRNA constructs, targeting HERVH. Knockdown effect was monitored by qRT-PCR detecting either HERVH-gag or HERVH-pol levels. Data shown are representative of two independent experiments with biological triplicates per experiment. shHERVH#3, shHERVH#4 and shHERVH#12 knocked-down ,80% of HERVH compared to the control shGFP. shHERVH#3, shHERVH#4 and shHERVH#12 (all shown in red) are also used in experiments presented in Fig. 3c-f . f, Representative immunostaining images showing reduction of pluripotency markers (OCT4, SOX2, SSEA4, and TRA-1-60) in both LBP9 and HERVH-depleted hESC_H9. shRNA against GFP was used as the control (shGFP). Scale bar, 100 mm. g, FACS analysis to determine the percentage of TRA-1-81 1 cells after depletion of LBP9 or HERVH. Three different shRNAs were employed to independently target LBP9 and HERVH, respectively. Data are presented as mean and s.d. (n 5 3 independent experiments with biological triplicates per experiment). h-j, Knockout of LBP9 in hESCs by the CRISPR/Cas9 technology. h, Experimental scheme to knockout LBP9 in hESCs using two guide RNAs (gRNAs), both targeting the second exon of LBP9. i, Analysis of LBP9 mutant hESC clones screened by genomic PCR. j, Sequence analysis of the TRA-1-81 sorted cells show that LBP9 mutants are found in differentiated (TRA-1-81
2 ) but not in undifferentiated (TRA-1-81 1 ) hESCs (representative samples). k, In contrast to human, Tfcp2l1 (mouse LBP9) depletion by shRNA does not affect self-renewal (left panel) in mouse ESCs in LIF/serum condition. Tfcp2l1-depleted mESCs were then differentiated into embryoid bodies (right panel), and endoderm and mesoderm markers were more expressed compared with shGFP mESC-derived embryoid bodies, indicating that Tfcp2l1-depleted mESCs have a bias to differentiate to endoderm and mesoderm (qRT-PCR analyses). Data are normalized to Gapdh, and relative to shGFP expressing, undifferentiated mESCs. Error bars indicate s.d. ND indicates undetectable. *P , 0.05, **P , 0.01, ***P , 0.001; t-test (n 5 3 independent experiments with biological triplicates per experiment).
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Extended Data Figure 8 | Characterization of LTR7-GFP-marked hPSCs. a, Genetically labelled (pT2-LTR7-GFP#2) human naive-like hESC_H9 and hiPSCs can be maintained in 2i/LIF medium for a longer period of time (followed by passage number 5 P9, .30 days) by re-plating (every 4-5 days), and by occasional sorting for the GFP marker. For optimal long-term culturing conditions, see Extended Data Fig. 7h . b, Single-cell cloning efficiency of GFP high versus GFP low hESC_H9. ALP-stained colonies were counted one week after plating 1,000 cells of a single cell suspension (with or without ROCK inhibitor (ROCKi)). Data were obtained from three independent experiments. Error bars indicate s.d., *P , 0.01, t-test. c, Both GFP high and GFP low hESCs_H9 are immunostained by the indicated pluripotency markers (OCT4, SOX2, SSEA4). Scale bar, 100 mm. d, GFP high cells can be differentiated, and display the markers of the three germ layers. Scale bar, 100 mm. e, qRT-PCR analysis of pluripotency-associated transcription factors during in vitro differentiation of GFP high and GFP low hESC_H9s. FACS-sorted GFP high and GFP low cells were cultured in human 2i/LIF medium and in conventional hESC medium for 3 days, respectively, before differentiation was triggered. Error bars indicate s.d. (n 5 3 independent experiments with biological triplicates per experiment), **P , 0.01, ***P , 0. RESEARCH LETTER
